DOI QR코드

DOI QR Code

Clinical disease characteristics according to karyotype in Turner syndrome

터너증후군에서 핵형에 따른 임상질환의 발병양상

  • Yeo, Chae Young (Department of Pediatrics, Chonnam National University Medical School) ;
  • Kim, Chan Jong (Department of Pediatrics, Chonnam National University Medical School) ;
  • Woo, Young Jong (Department of Pediatrics, Chonnam National University Medical School) ;
  • Lee, Dae Yeol (Department of Pediatric, Chonbuk National University Medical School) ;
  • Kim, Min Sun (Department of Pediatric, Chonbuk National University Medical School) ;
  • Kim, Eun Young (Department of Pediatrics, Kwangju Christian Hospital) ;
  • Kim, Jong Duck (Department of Pediatrics, Wonkwang University School of Medicine)
  • 여채영 (전남대학교 의과대학 소아과학교실) ;
  • 김찬종 (전남대학교 의과대학 소아과학교실) ;
  • 우영종 (전남대학교 의과대학 소아과학교실) ;
  • 이대열 (전북대학교 의학전문대학원 소아과학교실) ;
  • 김민선 (전북대학교 의학전문대학원 소아과학교실) ;
  • 김은영 (광주기독병원 소아청소년과) ;
  • 김종덕 (원광대학교 의학전문대학원 소아과학교실)
  • Received : 2009.09.04
  • Accepted : 2009.10.19
  • Published : 2010.02.15

Abstract

Purpose : Turner syndrome (TS) is a disorder in which various anomalies can be accompanied, especially cardiovascular, renal, thyroid and auditory problems. The aim of this study is to identify the incidence of these disorders in patients with TS according to karyotype. Methods : We reviewed medical records of 90 patients with TS diagnosed by chromosomal analysis in 4 hospitals from Jan 1998 to Dec 2007. We evaluated these cases by prepared protocol of 4 medical problems.Results : The distribution of karyotype was 45,X (47.8%), mosaic pattern (34.4%) and structural aberration group (17.8%). Renal anomalies, cardiovascular anomalies, thyroid disorders and auditory problems are accompanied in 4.4%, 10.0 %, 11.1% and 5.6%, respectively. 45,X group had renal anomalies (7.0%), cardiovascular anomalies (18.6%), thyroid disorders (9.3%) and auditory problems (11.6%). Mosaic group had renal anomalies (3.2%), thyroid disorders (12.9%), no cardiovascular anomalies and auditory problems. Structural aberration group had cardiovascular anomalies (6.3%), thyroid disorders (12.5%) and no other 2 problems. Patients with 45,X group had a significant higher incidence of cardiovascular anomalies (P =0.025). Conclusion : Our results indicate that there are differences clinically according to karyotype of TS, especially in incidence of cardiovascular anomalies.

목 적 : 터너증후군은 45,X의 전형적인 핵형 이외에도 다양한 정도의 X 염색체의 이상을 가진 질환으로 신장, 심혈관 기형, 갑상샘질환 및 청력이상을 동반하는 빈도가 많다. 본 연구에서는 핵형에 따른 동반질환의 발생빈도와 양상을 조사하였다. 방 법 : 1998년 1월부터 2007년 12월까지 호남지역 4개 병원에서 염색체검사상 터너증후군으로 확진된 90명의 의무기록을 후향적으로 분석하였다. 이들의 핵형을 45,X 군, 모자이시즘군, 구조적 이상군으로 분류하고 신장 및 심장초음파, 갑상샘기능검사, 청력검사 등을 통하여 동반질환의 발생빈도를 조사하였다. 결 과 : 45,X 군은 47.8%, 모자이시즘군은 34.4%, 구조적 이상군은 17.8%의 분포를 보였다. 신장, 심혈관 기형, 갑상샘질환, 청력이상은 각각 순서대로 4.4%, 10.0%, 11.1%, 5.6%의 빈도를 보였다. 45,X 군은 신장 기형이 7.0%, 심혈관 기형이 18.6% 갑상샘 질환이 9.3%, 청력이상이 11.6%에서 나타났다. 모자이시즘군은 신장기형이 3.2%, 갑상샘 질환이 12.9%의 발생율을 보였고 심혈관 기형과 청력이상이 있는 환자는 없었다. 구조적 이상군은 심혈관 기형이 6.3%, 갑상샘질환이 12.5%에서 나타났다. 45,X 군에서는 심혈관 질환의 발생율이 다른 두군에 비하여 통계적으로 유의하게 높았다(P =0.025). 결 론 : 터너증후군에서 핵형별로 동반질환의 분포가 다른 양상을 보였으며 적절한 선별검사를 통해 질환을 조기 진단하여 적절한 관리가 필요하리라 생각된다.

Keywords

References

  1. Gicquel C, Cabrol S, Schneid H, Girard F, Le Bouc Y. Molecular diagnosis of Turner’s syndrome. J Med Genet 1992;29:547-51 https://doi.org/10.1136/jmg.29.8.547
  2. Turner HH. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938;23:566–74 https://doi.org/10.1210/endo-23-5-566
  3. Ranke MB, Saenger P. Turner's syndrome. Lancet 2001;358:309-14 https://doi.org/10.1016/S0140-6736(01)05487-3
  4. Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 2004;151:657-87 https://doi.org/10.1530/eje.0.1510657
  5. Jang GC, Shin HJ, Kim DH. Clinical manifestations according to karyotype in Turner syndrome. J Korean Soc Pediatr Endocrinol 2000;5:163-70
  6. Choi YM, Jee BC, Choe J, Oh SK, Hwang DY, Suh CS, et al. Clinical and cytogenetic Features in Turner Syndrome. Korean J Obstet Gynecol 2000;43:295-301
  7. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-58 https://doi.org/10.1016/S0895-4356(97)00237-0
  8. Rapaport R. Hypofunction of ovaries. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Phildadelphia: Saunders Elsevier, 2007:2386-8
  9. Chung YH, Choi EK, Park YM, Park YH, Chung WY. Incidence of renal anomalies according to the karyotype in children with Turner syndrome. J Korean Soc Pediatr Endocrinol 2005;10:176-80
  10. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998;101:E11 https://doi.org/10.1542/peds.101.1.e11
  11. Elsheikh M, Wass JA, Conway GS. Autoimmune thyroid syndrome in women with Turner's syndrome-the association with karyotype. Clin Endocrinol (Oxf) 2001;55:223-6 https://doi.org/10.1046/j.1365-2265.2001.01296.x
  12. Kim JS, Kim SR, Chung WY. Otologic evaluation in children with Turner syndrome. J Korean Soc Pediatr Endocrinol 2005;10:71-5
  13. Flynn MT, Ekstrom L, De Arce M, Costigan C, Hoey HM. Prevalence of renal malformation in Turner syndrome. Pediatr Nephrol 1996;10:498-500 https://doi.org/10.1007/s004670050148
  14. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, et al. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001;86:3061-9 https://doi.org/10.1210/jc.86.7.3061
  15. Litvak AS, Rousseau TG, Wrede LD, Mabry CC, McRoberts JW. The association of significant renal anomalies with Turner's syndrome. J Urol 1978;120:671-2
  16. Kim PK, Kim JH, Chung SJ, Kim DH, Rho KS. The prevalence of renal malformation in Turner syndrome in Korea. J Korean Soc Pediatr Nephrol 1997;1:151-4
  17. Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner syndrome. Italian Study Group for Turner's Syndrome (ISGTS). J Pediatr 1998;133:688-92 https://doi.org/10.1016/S0022-3476(98)70119-2
  18. Lee MK, Jhang WK, Ko JM, Kim YH, Ko JK, Yoo HW, et al. Congenital cardiovascular malformations in patients with Turner syndrome. J Korean Pediatr Cardiol Soc 2006;10:292-8
  19. Mazzanti L, Prandstraller D, Tassinari D, Rubino I, Santucci S, Picchio FM, et al. Heart disease in Turner's syndrome. Helv Paediatr Acta 1988;43:25-31
  20. Prandstraller D, Mazzanti L, Picchio FM, Magnani C, Bergamaschi R, Perri A, et al. Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-Up of 136 nonpreselected patients. Pediatr Cardiol 1999;20:108-12 https://doi.org/10.1007/s002469900416
  21. Livadas S, Xekouki P, Fouka F, Kanaka-Gantenbein C, Kaloumenou I, Mavrou A, et al. Prevalence of thyroid dysfunction in Turner’s syndrome: A long-term follow-up study and brief literature review. Thyroid 2005;15:1061-6 https://doi.org/10.1089/thy.2005.15.1061
  22. Chiovato L, Larizza D, Bendinelli G, Tonacchera M, Marinó M, Mammoli C, et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner's syndrome. Eur J of Endocrinol 1996;13:568-75 https://doi.org/10.1530/eje.0.1340568
  23. Ivarsson SA, Ericsson UB, Nilsson KO, Gustafsson J, Hagenäs L, Häger A, et al. Thyroid autoantibodies, Turner's syndrome and growth hormone therapy. Acta Paediatr 1995;84:63-5 https://doi.org/10.1111/j.1651-2227.1995.tb13485.x
  24. G$\"{u}$ng$\"{o}$r N, B$\"{o}$ke B, Belgin E, Tun$\c{c}$bilek E. High frequency hearing loss in Ullrich-Turner syndrome. Eur J Pediatr 2000;159:740-4 https://doi.org/10.1007/PL00008338
  25. Wright A, Davis A, Bredberg G, Ulehlova L, Spencer H. Hair cell distributions in the normal human cochlea. Acta Otolaryngol Suppl 1987;444:1-48
  26. Bondy CA. Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J Neurosci 1991;11:3442-55
  27. Barren$\"{a}$s ML, Nyl$\'{e}$n O, Hanson C. The influence of karyotype on the auricle, otitis media and hearing in Turner syndrome. Hear Res 1999;138:163-70 https://doi.org/10.1016/S0378-5955(99)00162-8

Cited by

  1. A Case of Turner Syndrome Associated with Idiopathic Central Diabetes Insipidus vol.16, pp.1, 2011, https://doi.org/10.6065/jkspe.2011.16.1.56